重新检查怀孕期间恶心和吐的适应功能
1UCL Anthropology, University College London, London WC1H 0BW, UK.
Evolution, medicine, and public health
|July 17, 2024
概括
怀孕中恶心和吐 (NVP) 可能不是纯粹的保护性. 新的研究表明,温和的NVP可能有利于胎儿的结果,而严重的病例则存在风险,特别是在现代环境中.
科学领域:
- 进化生物学是进化的生物学.
- 生殖健康 生殖健康
- 产周医学 产周医学
背景情况:
- 怀孕中恶心和吐 (NVP) 已被理论化为具有保护性的进化功能.
- 最近的研究为与NVP相关的机制和结果提供了新的见解.
研究的目的:
- 根据当前的科学发现,重新审视NVP的进化观点.
- 评估NVP特征与拟议的预防功能之间的一致性.
主要方法:
- 对NVP现有的科学文献的审查.
- 对NVP病因和结果的新研究进行分析.
- 进化观点分析. 进化观点分析.
主要成果:
- 目前的NVP特征并不强烈支持一个简单的预防功能.
- 中度至重度的NVP与不良的胎儿/分娩结果有关.
- 怀孕早期轻度NVP可能与改善胎儿结果相关.
- 增长差异化因素15 (GDF15) 被确定为NVP的一个原因.
- 低预孕GDF15可能会增加NVP风险/症状.
结论:
- NVP的作用是复杂的,在轻微的形式中可能有好处,但在严重的情况下可能存在风险.
- 后工业化社会中的环境因素可能会加剧NVP的严重程度.
- 现代人群中典型的NVP体验可能与祖先的规范有所不同.
更多相关视频
相关概念视频
Pathophysiology of Vomiting
366
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
366
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
158
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
158
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
244
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
244
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
191
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
191
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
209
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
209
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
293
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
293


